Company Great Novel Therapeutics Biotech & Medicals

Equities

7427

TW0007427007

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Biotechnology & Medical Research

GREAT NOVEL THERAPEUTICS BIOTECH & MEDICALS

End-of-day quote Taipei Exchange Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
52 ^TWD	0.00%		-1.52%	-22.16%

20/03	Great Novel Therapeutics Biotech & Medicals Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Great Novel Therapeutics Biotech & Medicals(TPEX:7427) added to S&P Global BMI Index	CI

GNT Biotech & Medicals Corp is a Taiwan-based company mainly engaged in the research, development and clinical trials of oral anti-cancer targeted new drugs. The main product is the oral anti-cancer targeted new drug TM/Kepida, which is mainly used for the treatment of relapsed and refractory peripheral T-cell lymphoma (R/R PTCL) and ER+/Her-2-advanced breast cancer (ER+/Her-2-BC). The Company is also engaged in the research and development of tumor immunotherapies. The products include GNTbm-CC-01 and GNTbm-CC-02, which are tumor microenvironment regulator new drug combinations, as well as GNTbm-38, which is surface immunomodulator.

Number of employees: 12

TWD in Million	2022	Weight	2023	Weight	Delta
Cancer Medical Treatment 100.0 %	1	100.0 %	5	100.0 %	+798.15%

TWD in Million	2022	Weight	2023	Weight	Delta
Taiwan 100.0 %	1	100.0 %	5	100.0 %	+798.15%

Managers	Title	Age	Since
Chia Nan Chen CEO	Chief Executive Officer	-	03/13/03
Ying Chang Huang DFI	Director of Finance/CFO	-	04/21/04

Members of the board	Title	Age	Since
Hung Jen Wu BRD	Director/Board Member	-	26/13/26
Chung Yang Huang BRD	Director/Board Member	-	02/17/02
Tien Tzu Tseng BRD	Director/Board Member	-	14/21/14
Hung Hui Cheng BRD	Director/Board Member	-	-
Chia Nan Chen CEO	Chief Executive Officer	-	03/13/03
Ming Hsuan Li BRD	Director/Board Member	-	-
Ming I Huang BRD	Director/Board Member	-	02/17/02
Chung Hsi Chen BRD	Director/Board Member	-	-
Shang Pu Hsia BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	38,486,985	38,486,985 ( 100.00 %)	0	100.00 %

Great Novel Therapeutics Biotech & Medicals Corp.

17/F, Block F, 3 Park Street Nangang District

115 03, Taipei

http://www.gntbm.com.tw

address Great Novel Therapeutics Biotech & Medicals(7427)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
GREAT NOVEL THERAPEUTICS BIOTECH & MEDICALS	-22.16%	6.22Cr
IQVIA HOLDINGS INC.	-0.09%	4.21TCr
LONZA GROUP AG	+49.62%	4.2TCr
CELLTRION, INC.	-4.96%	2.92TCr
ICON PUBLIC LIMITED COMPANY	+11.18%	2.6TCr
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	1.89TCr
BIO-TECHNE CORPORATION	+8.61%	1.32TCr
UNITED THERAPEUTICS CORPORATION	+24.73%	1.22TCr
MEDPACE HOLDINGS, INC.	+28.31%	1.22TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-6.26%	1.14TCr

Other Biotechnology & Medical Research